当前位置：
X-MOL 学术
›
N. Engl. J. Med.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2024-06-27 , DOI: 10.1056/nejmoa2312282 Mirna Chehade 1 , Evan S. Dellon 1 , Jonathan M. Spergel 1 , Margaret H. Collins 1 , Marc E. Rothenberg 1 , Robert D. Pesek 1 , Ikuo Hirano 1 , Ruiqi Liu 1 , Elizabeth Laws 1 , Eric Mortensen 1 , Renata Martincova 1 , Arsalan Shabbir 1 , Eilish McCann 1 , Mohamed A. Kamal 1 , Matthew P. Kosloski 1 , Jennifer D. Hamilton 1 , Carin Samuely 1 , Wei Keat Lim 1 , Matthew F. Wipperman 1 , Annamaria Farrell 1 , Naimish Patel 1 , George D. Yancopoulos 1 , Lila Glotfelty 1 , Jennifer Maloney 1
The New England Journal of Medicine ( IF 96.2 ) Pub Date : 2024-06-27 , DOI: 10.1056/nejmoa2312282 Mirna Chehade 1 , Evan S. Dellon 1 , Jonathan M. Spergel 1 , Margaret H. Collins 1 , Marc E. Rothenberg 1 , Robert D. Pesek 1 , Ikuo Hirano 1 , Ruiqi Liu 1 , Elizabeth Laws 1 , Eric Mortensen 1 , Renata Martincova 1 , Arsalan Shabbir 1 , Eilish McCann 1 , Mohamed A. Kamal 1 , Matthew P. Kosloski 1 , Jennifer D. Hamilton 1 , Carin Samuely 1 , Wei Keat Lim 1 , Matthew F. Wipperman 1 , Annamaria Farrell 1 , Naimish Patel 1 , George D. Yancopoulos 1 , Lila Glotfelty 1 , Jennifer Maloney 1
Affiliation
Dupilumab is a human monoclonal antibody that blocks interleukin-4 and interleukin-13 pathways and has shown efficacy in five different atopic diseases marked by type 2 inflammation, including eosi...
中文翻译：
Dupilumab 治疗 1 至 11 岁患者的嗜酸性食管炎
Dupilumab 是一种人单克隆抗体，可阻断白细胞介素 4 和白细胞介素 13 通路，并已在五种以 2 型炎症为特征的不同特应性疾病中显示出疗效，包括 eosi...
更新日期：2024-06-27
中文翻译：
Dupilumab 治疗 1 至 11 岁患者的嗜酸性食管炎
Dupilumab 是一种人单克隆抗体，可阻断白细胞介素 4 和白细胞介素 13 通路，并已在五种以 2 型炎症为特征的不同特应性疾病中显示出疗效，包括 eosi...
京公网安备 11010802027423号